|
AP2002002460A0
(en)
|
2001-03-09 |
2002-06-30 |
Pfizer Prod Inc |
Novel benzimidazole anti-inflammatory compounds.
|
|
US7803553B2
(en)
|
2003-09-04 |
2010-09-28 |
Riken |
Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β
|
|
US20070276050A1
(en)
|
2006-02-27 |
2007-11-29 |
Gilead Sciences, Inc. |
Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases
|
|
PT2303270T
(pt)
|
2008-05-05 |
2017-08-25 |
Sanofi Sa |
Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
|
|
US8455499B2
(en)
|
2008-12-11 |
2013-06-04 |
Amira Pharmaceuticals, Inc. |
Alkyne antagonists of lysophosphatidic acid receptors
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
GB2470833B
(en)
|
2009-06-03 |
2011-06-01 |
Amira Pharmaceuticals Inc |
Polycyclic antagonists of lysophosphatidic acid receptors
|
|
TWI598347B
(zh)
|
2009-07-13 |
2017-09-11 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
|
CN102574822A
(zh)
|
2009-08-04 |
2012-07-11 |
阿米拉制药公司 |
作为溶血磷脂酸受体拮抗剂的化合物
|
|
KR101678255B1
(ko)
|
2009-09-25 |
2016-11-21 |
아스텔라스세이야쿠 가부시키가이샤 |
치환 아미드 화합물
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
WO2011159550A2
(en)
|
2010-06-14 |
2011-12-22 |
Amidra Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonist and uses thereof
|
|
WO2011159632A1
(en)
|
2010-06-15 |
2011-12-22 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
|
|
PH12012500542A1
(en)
|
2010-09-24 |
2012-11-12 |
Astellas Pharma Inc |
Substituted amide compound
|
|
DK2648726T3
(da)
|
2010-12-07 |
2018-07-16 |
Amira Pharmaceuticals Inc |
Polycyklisk lpa1-antagonist og anvendelser deraf
|
|
KR20130126659A
(ko)
|
2010-12-07 |
2013-11-20 |
아미라 파마슈티칼스 인코포레이티드 |
리소포스파티드산 수용체 길항제 및 섬유증 치료에서의 그의 용도
|
|
US8785442B2
(en)
|
2011-01-30 |
2014-07-22 |
Curegenix, Inc. |
Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
|
|
WO2012138797A1
(en)
|
2011-04-05 |
2012-10-11 |
Amira Pharmaceuticals, Inc. |
3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
JP2014525932A
(ja)
|
2011-08-15 |
2014-10-02 |
インターミューン， インコーポレイテッド |
リゾホスファチド酸レセプターアンタゴニスト
|
|
RS57157B1
(sr)
|
2011-11-11 |
2018-07-31 |
Gilead Apollo Llc |
Acc inhibitori i njihove primene
|
|
US20140329871A1
(en)
|
2011-12-04 |
2014-11-06 |
Angion Biomedica Corp. |
Small molecule anti-fibrotic compounds and uses thereof
|
|
UY34573A
(es)
|
2012-01-27 |
2013-06-28 |
Gilead Sciences Inc |
Inhibidor de la quinasa que regula la señal de la apoptosis
|
|
US9518112B2
(en)
|
2012-03-08 |
2016-12-13 |
Ludwig Institute For Cancer Research Ltd |
TGF-β1 specific antibodies and methods and uses thereof
|
|
SG11201407229UA
(en)
|
2012-06-20 |
2014-12-30 |
Hoffmann La Roche |
Substituted pyrazole compounds as lpar antagonists
|
|
JP2015520202A
(ja)
|
2012-06-20 |
2015-07-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｌｐａｒ拮抗薬としてのｎ−アルキルトリアゾール化合物
|
|
IN2014DN09352A
(https=)
|
2012-06-20 |
2015-07-17 |
Hoffmann La Roche |
|
|
WO2014037303A1
(en)
|
2012-09-05 |
2014-03-13 |
F. Hoffmann-La Roche Ag |
Lpar - substituted cyanopyrazole compounds
|
|
WO2014072486A1
(en)
|
2012-11-09 |
2014-05-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New benzene sulfonamide thiazole compounds
|
|
KR102189166B1
(ko)
|
2012-12-28 |
2020-12-09 |
우베 고산 가부시키가이샤 |
할로겐 치환 헤테로환 화합물
|
|
US20140213538A1
(en)
|
2013-01-15 |
2014-07-31 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
WO2014145873A2
(en)
|
2013-03-15 |
2014-09-18 |
Epigen Biosciences, Inc. |
Heterocyclic compounds useful in the treatment of disease
|
|
EP2994139B1
(en)
|
2013-05-10 |
2019-04-10 |
Gilead Apollo, LLC |
Acc inhibitors and uses thereof
|
|
ES2860952T3
(es)
|
2013-08-01 |
2021-10-05 |
Univ Catholique Louvain |
Proteína anti-garp y usos de la misma
|
|
GB201314926D0
(en)
|
2013-08-20 |
2013-10-02 |
Takeda Pharmaceutical |
Novel Compounds
|
|
US9987381B2
(en)
|
2013-10-31 |
2018-06-05 |
Bristol-Myers Squibb Company |
Radioligands for imaging the LPA-1 receptor
|
|
RU2689315C2
(ru)
|
2014-06-27 |
2019-05-27 |
Убе Индастриз, Лтд. |
Соль гетероциклического соединения, замещенного галогеном
|
|
WO2016115345A1
(en)
|
2015-01-14 |
2016-07-21 |
The Brigham And Women's Hospital, |
Treatment of cancer with anti-lap monoclonal antibodies
|
|
EP3378491A4
(en)
|
2015-11-20 |
2019-07-17 |
UBE Industries, Ltd. |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF NASH
|
|
SG11201807077RA
(en)
|
2016-03-02 |
2018-09-27 |
Gilead Apollo Llc |
Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
|
|
AR108185A1
(es)
|
2016-04-06 |
2018-07-25 |
Abbvie Inc |
Amidas terciarias y método para su uso
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
BR112019013908A2
(pt)
|
2017-01-06 |
2020-02-04 |
Scholar Rock, Inc. |
inibidores de tgfss1 isoforma-específicos, contexto-permissivos, e seus usos
|
|
WO2019041340A1
(en)
|
2017-09-04 |
2019-03-07 |
Eli Lilly And Company |
LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1)
|
|
WO2019113123A1
(en)
|
2017-12-04 |
2019-06-13 |
Precithera, Inc. |
TGF-ß RECEPTOR FUSION PROTEINS AND OTHER TGF-ß ANTAGONISTS FOR REDUCING TGF-ß SIGNALING
|
|
EP3720881A1
(en)
|
2017-12-08 |
2020-10-14 |
Elstar Therapeutics, Inc. |
Multispecific molecules and uses thereof
|
|
WO2019126084A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
EP3728216B1
(en)
|
2017-12-19 |
2023-09-06 |
Bristol-Myers Squibb Company |
Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
EP3728209B1
(en)
|
2017-12-19 |
2025-12-24 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as lpa antagonists
|
|
ES2898364T3
(es)
|
2017-12-19 |
2022-03-07 |
Bristol Myers Squibb Co |
Acidos carbamoilciclohexílicos ligados a N triazol como antagonistas de LPA
|
|
CN111712492B
(zh)
|
2017-12-19 |
2024-05-31 |
百时美施贵宝公司 |
作为lpa拮抗剂的环己基酸三唑唑类
|
|
JP7208240B2
(ja)
|
2017-12-19 |
2023-01-18 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
|
|
JP7299892B2
(ja)
|
2017-12-19 |
2023-06-28 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアジン
|
|
CN112041302B
(zh)
|
2017-12-19 |
2024-11-19 |
百时美施贵宝公司 |
作为lpa拮抗剂的吡唑o-连接的氨基甲酰基环己基酸
|
|
US11261180B2
(en)
|
2017-12-19 |
2022-03-01 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as LPA antagonists
|
|
EP3853232B1
(en)
|
2018-09-18 |
2023-03-01 |
Bristol-Myers Squibb Company |
Oxabicyclo acids as lpa antagonists
|
|
ES2948793T3
(es)
|
2018-09-18 |
2023-09-19 |
Bristol Myers Squibb Co |
Acidos cicloheptílicos como antagonistas de LPA
|
|
ES2946657T3
(es)
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
US20210379210A1
(en)
|
2018-10-15 |
2021-12-09 |
Bristol-Myers Squibb Company |
Radioligands for imaging the lpa1 receptor
|
|
CN114599640A
(zh)
|
2019-06-18 |
2022-06-07 |
百时美施贵宝公司 |
作为lpa拮抗剂的异噁唑羧酸
|
|
EP3986553B1
(en)
|
2019-06-18 |
2026-03-25 |
Bristol-Myers Squibb Company |
Cyclobutyl carboxylic acids as lpa antagonists
|
|
WO2020257135A1
(en)
|
2019-06-18 |
2020-12-24 |
Bristol-Myers Squibb Company |
Triazole carboxylic acids as lpa antagonists
|
|
PH12022550225A1
(en)
|
2019-07-30 |
2022-12-19 |
Taisho Pharmaceutical Co Ltd |
Urea compound for antagonizing lpa1 receptor
|
|
EP4058144A1
(en)
|
2019-11-15 |
2022-09-21 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
|
|
JP7665619B2
(ja)
|
2019-12-04 |
2025-04-21 |
イドルシア・ファーマシューティカルズ・リミテッド |
線維性疾患の治療に使用するためのアゼチジンｌｐａ１受容体アンタゴニストのピルフェニドン及び／又はニンテダニブとの合剤
|
|
TWI843503B
(zh)
*
|
2020-06-03 |
2024-05-21 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
EP4161936A1
(en)
|
2020-06-03 |
2023-04-12 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
CA3185111A1
(en)
*
|
2020-07-16 |
2022-01-20 |
Elisabetta Armani |
Amido cyclohexane acid derivatives as lpa receptor inhibitors
|
|
WO2022034568A1
(en)
|
2020-08-11 |
2022-02-17 |
Viva Star Biosciences Limited |
Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists
|
|
CN114456147B
(zh)
|
2020-11-10 |
2025-07-15 |
武汉人福创新药物研发中心有限公司 |
氧取代氨基碳酸酯噻吩类化合物
|
|
CN114456159A
(zh)
|
2020-11-10 |
2022-05-10 |
武汉人福创新药物研发中心有限公司 |
氮取代杂环噻吩类化合物及其用途
|
|
CN114456157A
(zh)
|
2020-11-10 |
2022-05-10 |
武汉人福创新药物研发中心有限公司 |
氮取代氨基碳酸酯噻吩类化合物及其用途
|
|
WO2022174882A1
(en)
|
2021-02-16 |
2022-08-25 |
Chiesi Farmaceutici S.P.A. |
5-membered heterocyclyl carbamate derivatives as dual lpa receptor 1 and lpa receptor 2 inhibitors
|
|
WO2022174883A1
(en)
|
2021-02-16 |
2022-08-25 |
Chiesi Farmaceutici S.P.A. |
5-membered heterocyclyl derivatives as dual lpa receptor 1 and lpa receptor 2 inhibitors
|
|
WO2022240879A1
(en)
|
2021-05-11 |
2022-11-17 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
|
KR20240007233A
(ko)
|
2021-05-13 |
2024-01-16 |
길리애드 사이언시즈, 인코포레이티드 |
Lpa 수용체 길항제 및 이의 용도
|